These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
234 related items for PubMed ID: 9201058
1. Comparative analysis of brain protection by N-methyl-D-aspartate receptor antagonists after transient focal ischemia in cats. Miyabe M, Kirsch JR, Nishikawa T, Koehler RC, Traystman RJ. Crit Care Med; 1997 Jun; 25(6):1037-43. PubMed ID: 9201058 [Abstract] [Full Text] [Related]
6. Effect of D-(E)-2-amino-4-methyl-5-phosphono-3-pentenoic acid on focal cerebral ischemia in cat. Okada M, Ueda H, Kometani M, Nakao K. Arzneimittelforschung; 1997 Jun; 47(6):703-5. PubMed ID: 9239446 [Abstract] [Full Text] [Related]
7. Pharmacological profile of NPC 17742 [2R,4R,5S-(2-amino-4,5-(1, 2-cyclohexyl)-7-phosphonoheptanoic acid)], a potent, selective and competitive N-methyl-D-aspartate receptor antagonist. Ferkany JW, Hamilton GS, Patch RJ, Huang Z, Borosky SA, Bednar DL, Jones BE, Zubrowski R, Willetts J, Karbon EW. J Pharmacol Exp Ther; 1993 Jan; 264(1):256-64. PubMed ID: 8423528 [Abstract] [Full Text] [Related]
8. Synergistic effects of citicoline and MK-801 in temporary experimental focal ischemia in rats. Onal MZ, Li F, Tatlisumak T, Locke KW, Sandage BW, Fisher M. Stroke; 1997 May; 28(5):1060-5. PubMed ID: 9158650 [Abstract] [Full Text] [Related]
9. Pharmacological specificity of the discriminative stimulus properties of 2-amino-4,5-(1,2-cyclohexyl)-7-phosphono-heptanoic acid (NPC 12626), a competitive N-methyl-D-aspartate receptor antagonist. Bobelis DJ, Balster RL. J Pharmacol Exp Ther; 1993 Feb; 264(2):845-53. PubMed ID: 8437128 [Abstract] [Full Text] [Related]
10. Isoflurane and pentobarbital reduce the frequency of transient ischemic depolarizations during focal ischemia in rats. Patel PM, Drummond JC, Cole DJ, Kelly PJ, Watson M. Anesth Analg; 1998 Apr; 86(4):773-80. PubMed ID: 9539600 [Abstract] [Full Text] [Related]
11. Protection by N-methyl-D-aspartate receptor antagonists against impairment of working memory in rats following transient cerebral ischemia. Ohno M, Yamamoto T, Ueki S, Watanabe S. Neurosci Lett; 1992 Apr 13; 138(1):1-4. PubMed ID: 1407646 [Abstract] [Full Text] [Related]
12. Anti-ischaemic efficacy of a nitric oxide synthase inhibitor and a N-methyl-D-aspartate receptor antagonist in models of transient and permanent focal cerebral ischaemia. Dawson DA, Graham DI, McCulloch J, Macrae IM. Br J Pharmacol; 1994 Sep 13; 113(1):247-53. PubMed ID: 7529111 [Abstract] [Full Text] [Related]
13. Neuroprotective effect of D-(E)-2-amino-4-methyl-5-phosphono-3-pentenoic acid in the gerbil model of transient global cerebral ischemia. Okada M, Ueda H, Kometani M, Nakao K, Kohjimoto Y, Takahashi I, Tanaka I. Arzneimittelforschung; 1997 Jun 13; 47(6):700-2. PubMed ID: 9239445 [Abstract] [Full Text] [Related]
14. Effects of ifenprodil, a polyamine site NMDA receptor antagonist, on reperfusion injury after transient focal cerebral ischemia. Doğan A, Rao AM, Başkaya MK, Rao VL, Rastl J, Donaldson D, Dempsey RJ. J Neurosurg; 1997 Dec 13; 87(6):921-6. PubMed ID: 9384405 [Abstract] [Full Text] [Related]
15. NMDA receptor blockade fails to alter axonal injury in focal cerebral ischemia. Yam PS, Dunn LT, Graham DI, Dewar D, McCulloch J. J Cereb Blood Flow Metab; 2000 May 13; 20(5):772-9. PubMed ID: 10826527 [Abstract] [Full Text] [Related]
16. Experimental neuronal injury in the newborn lamb: a comparison of N-methyl-D-aspartic acid receptor blockade and nitric oxide synthesis inhibition on lesion size and cerebral hyperemia. Taylor GA, Trescher WH, Johnston MV, Traystman RJ. Pediatr Res; 1995 Nov 13; 38(5):644-51. PubMed ID: 8552428 [Abstract] [Full Text] [Related]
17. Regionally selective effects of NMDA receptor antagonists against ischemic brain damage in the gerbil. Warner MA, Neill KH, Nadler JV, Crain BJ. J Cereb Blood Flow Metab; 1991 Jul 13; 11(4):600-10. PubMed ID: 1828809 [Abstract] [Full Text] [Related]
18. Protective effect of the glutamate antagonist, MK-801 in focal cerebral ischemia in the cat. Ozyurt E, Graham DI, Woodruff GN, McCulloch J. J Cereb Blood Flow Metab; 1988 Feb 13; 8(1):138-43. PubMed ID: 2892846 [Abstract] [Full Text] [Related]
19. The competitive NMDA antagonist, CGS-19755, improves postischemic hypoperfusion in selectively vulnerable regions in gerbils. Omae T, Hasegawa Y, Ogata J, Tamaki K, Minematsu K, Yamaguchi T. J Neurol Sci; 1996 Jun 13; 138(1-2):105-13. PubMed ID: 8791247 [Abstract] [Full Text] [Related]
20. The competitive NMDA receptor antagonist CGP 40116 is a potent neuroprotectant in a rat model of focal cerebral ischemia. Sauer D, Allegrini PR, Fagg GE. J Neural Transm Suppl; 1994 Jun 13; 43():81-9. PubMed ID: 7884410 [Abstract] [Full Text] [Related] Page: [Next] [New Search]